Roundtable Discussion: Analyzing Biomarker Targets to Evaluate Treatment Efficacy & Improve Patient Access
- Exploring predictive, pharmacodynamic & mechanistic biomarkers to link biological response with clinical efficacy
- Using biomarker to improve patient access to advanced therapies
- Defining new biomarker approaches to monitor safety & response in emerging platforms including in vivo CAR-T